WGS

GeneDx Holdings Corp.

WGS · CIK 1818331 · Annual (10-K) · Last 6 years

Financial Trends

Revenue$428M
20202025
Net Income−$21M
20202025
Operating CF$33M
20202025
Free Cash Flow$14M
20202025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Revenue$0.4B$0.3B$0.2B$0.2B$0.1B—
Cost of Revenue$0.1B$0.1B$0.1B$0.3B$0.1B—
Gross Profit$0.3B$0.2B$0.1B$-0.0B$-0.0B—
R&D Expense$0.1B$0.0B$0.1B$0.1B$0.0B—
SG&A Expense——————
Operating Income$-0.0B$-0.0B$-0.2B$-0.7B$-0.1B$-0.0B
Net Income$-0.0B$-0.1B$-0.2B$-0.5B$-0.0B$-0.0B
EPS (Basic)$-0.73$-1.94$-7.23$-1.63$-2.27—
EPS (Diluted)$-0.73$-1.94$-7.23$-1.63$-2.27—

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Total Assets$0.5B$0.4B$0.4B$0.5B$0.6B$0.4B
Current Assets$0.3B$0.2B$0.2B$0.2B$0.5B$0.0B
Cash & Equivalents$0.1B$0.1B$0.1B$0.1B$0.4B$0.0B
Total Liabilities$0.2B$0.2B$0.2B$0.2B$0.2B$0.0B
Current Liabilities$0.1B$0.1B$0.1B$0.1B$0.1B$0.0B
Stockholders' Equity$0.3B$0.2B$0.2B$0.3B$0.4B$0.0B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕FY 2021↕FY 2020↕
Operating Cash Flow$0.0B$-0.0B$-0.2B$-0.3B$-0.2B$-0.0B
Investing Cash Flow$-0.1B$-0.0B$-0.0B$-0.1B$-0.0B$-0.4B
Capital Expenditures$0.0B$0.0B$0.0B$0.0B$0.0B—
Financing Cash Flow$0.0B$0.0B$0.2B$0.2B$0.5B$0.4B
← Companies